Skip to content
11
Categories
Meet the Expert

Chemo-flexibility in the era of immunotherapy: How can ICI-chemotherapy combinations be optimized in non-Oncogene- driven NSCLC?

- , Delhi

Schedule Slot

Chemo-flexibility in the era of immunotherapy: How can ICI-chemotherapy combinations be optimized in non-Oncogene- driven NSCLC?

11
Categories
Meet the Expert

Chemo-flexibility in the era of immunotherapy: How can ICI-chemotherapy combinations be optimized in non-Oncogene- driven NSCLC?

- , Delhi

Endorsed by: Regeneron

Chair:
Alessandra Curioni-Fontecedro (Cantonal Hospital and University of Fribourg)